Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Diabetes Treatment: A novel ‘Flexible’ Approach discovered!

Allopathy and AYUSH - The Systems of Medicine in India

The universe expansion: New theories proposed!

Diabetes Treatment: A novel ‘Flexible’ Approach discovered!
  • BiotechToday
  • World

Diabetes Treatment: A novel ‘Flexible’ Approach discovered!

BioTech Today January 25, 2022January 25, 2022

Subhajit Nan, Amity University, Kolkata

Through new research, scientists suggest that the conformational flexibility of peptides makes them more effective in the second type of diabetes treatment.

For those who are unversed, peptides refer to the short chunks of proteins. Many hormones are in-fact peptides, such as insulin and glucagon. These peptides provide important information to cells that affect metabolism, like regulating sugar levels in the blood.

Peptides constitute the most important components of the molecular signaling mechanism as they pass the information by binding to specialized receptor proteins on the exterior of a cell, thereby activating them and initiating the signaling pathway.

What is Type-2 diabetes?

The second type of diabetes is clinically known as Type-2 diabetes. It is described as a disorder pertaining to the glucose metabolism of the body. In the long term, this condition results in high levels of blood sugar. This, in turn, leads to nervous, circulatory, and immune systems malfunctioning.

The peptide used to promote insulin release, and therefore prevent Type-2 diabetes, is known as ‘GLP-1’. We had previously known that it adopted a rigidly helical, corkscrew shape. Scientists had hypothesized that the peptide followed a ‘lock-and-key’ relationship with the cellular receptor. This meant that the peptide would be required to possess a rigid and exact shape to function properly and effectively.

The new ‘flexible’ approach discovered for diabetes treatment:

In this new study, this conventional knowledge was contradicted. The scientists engineered a peptide with sudden ‘kink’, or constriction, near its end. When they compared this engineered peptide with a peptide locked with a rigid helical shape, they found that the engineered ‘flexible’ peptide was more effective in activating its cellular target receptor, which stimulates the release of the hormone insulin from the pancreas, which ultimately lowers the high sugar levels in the bloodstream.

When the research team conducted their experiments using these two different shapes, they found that the helical peptides bound strongly to the receptor but were not as effective in activating it. On the contrary, kinked peptides couldn’t bind very strongly, yet they activated the cellular receptor very effectively when eventually docked in.

These observations led the team to come up with a new model GLP-1’s structure in correlation with its function. Through their new model, they suggested that GLP-1 binds to its target and activates it as a helical structure, and fits perfectly, following the lock-and-key hypothesis. Then, GLP-1 switches to a new ‘conformation’, or shape, with a constricted end. The constriction, or kink, helps reorganize the GLP-1’s cellular receptor, preparing it to send a new molecular signal. The peptide then again reverts to its helical shape to anchor with its cellular receptor once again and the cycle repeats itself.

Consequently, the scientists concluded that GLP-1 peptide possesses a flexible conformation and is capable of switching ‘back-and-forth’ between these two forms, or configurations, to maximize its effectiveness in signal transduction. Their discoveries have the potential to improve the design for these diabetes therapeutic drugs and possibly other therapeutic peptides, and hence facilitate diabetes treatment in general.

Also read: Universal influenza vaccine under development

Reference:

  1. Cary, Brian P., et al. ‘Structural and Functional Diversity among Agonist-Bound States of the GLP-1 Receptor’. Nature Chemical Biology, Dec. 2021, pp. 1–8. www.nature.com, https://doi.org/10.1038/s41589-021-00945-w.
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Author info:

Subhajit Nan is an aspiring biotechnologist, living in Kolkata. He is currently in his second year, pursuing a Bachelor of Science (Honours) in the field, from Amity University, Kolkata. He has completed his schooling at Calcutta Boys’ School in the Science stream. He has a keen interest in scientific research and writing. He likes debating, playing chess, and swimming in various competitions.

Other Publications of the Author: –

  1. https://bioxone.in/news/worldnews/apples-give-info-on-co-evolution-of-host-and-microbiome/
  2. https://bioxone.in/news/early-decrease-in-atmospheric-co2-concentration-caused-polar-ice-formation/
  3. https://bioxone.in/news/worldnews/exploiting-plant-response-to-arsenic-contamination-in-soil-for-human-welfare/

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged back-and-forth movement blood sugar conformation Diabetes flexible GLP-1 insulin kink lock and key lock and key hypothesis lock-and-key hypothesis receptor signal transduction therapeutic drugs treatment type-2 diabetes

One thought on “Diabetes Treatment: A novel ‘Flexible’ Approach discovered!”

  1. Pingback: RNA-Lipid interactions: What do they tell us about the origin of life? - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

The universe expansion: New theories proposed!

BioTech Today January 25, 2022

Rutuja M. Borawke, M.E.S. Abasaheb Garware College, Pune Scientists from Physical Research Laboratory (PRL), Ahmedabad & IISc Bangalore have compiled research that focuses on examining the driving force for expanding the universe & the nature of dark energy. Mohanty from PRL clears the fact that only 5% of the universe is understood. The remaining is […]

The universe

Related Post

  • BiotechToday
  • World

Drug-Resistant Cell Line Development in Tumor Research

BioTech Today August 4, 2021August 3, 2021

Agrima Bhatt, Rajasthan University Many cancer patients are responsive to chemotherapy at the initial stages of treatment. Although, during treatment, they may develop resistance which makes cancer difficult to diagnose. This is of huge clinical concern in such sensitive treatments as it can later convert into huge barricades in patient’s lives. In clinical cancer treatment, […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Deep Learning Algorithms: A Predictor of Cardiovascular Disease?

bioxone May 5, 2021May 5, 2021

Ayooshi Mitra, Amity University Kolkata Deep Learning, a popular artificial intelligence method, is a powerful tool for surveying and categorizing biological data. Deep-learning tools could also assist researchers in stratifying disease types, understanding disease subpopulations, discovering new treatments, and matching them with suitable patients for clinical testing and treatment. A deep learning (DL) algorithm that […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Impact of pregnancy metabolome on birthweight variations

bioxone July 14, 2021July 13, 2021

Avani Dave, Jai Hind College The metabolomics assays have been gaining traction as they allow the simultaneous identification of hundreds of molecular metabolic products, present in biofluids and describes the exogenous exposures along with the downstream signalling response initiated thereafter. A well-registered benefit of the metabolomics assay lies in its capability to demonstrate associations with […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy